Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liver Neoplasms × Interleukin-2 × Clear all

Sponsor

Conditions

Melanoma 33 Neoplasm Metastasis 16 Leukemia, Myeloid, Acute 11 Skin Neoplasms 9 Leukemia 9 Kidney Neoplasms 9 Carcinoma, Renal Cell 9 Neoplasms 7 Ovarian Neoplasms 6 Breast Neoplasms 6 Lymphoma 5 Lymphoma, Non-Hodgkin 4 Congenital Abnormalities 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Papillomavirus Infections 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vulvar Diseases 1

Interventions

Sorafenib 22 Bevacizumab 10 Capecitabine 6 Radiofrequency Ablation 5 Oxaliplatin 5 Fluorouracil 5 Doxorubicin 5 pembrolizumab 4 Sunitinib 4 Radiosurgery 4 Cisplatin 4 Ramucirumab 3 Radiotherapy 3 Leucovorin 3 Erlotinib Hydrochloride 3 Carboplatin 3 tremelimumab 2 spartalizumab 2 perflutren 2 derazantinib 2 carotuximab 2 Nivolumab 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Immunohistochemistry 2 Gemcitabine 2 Folfox protocol 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡